Treatment of refractory heart failure with infusion of nitroprusside.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D009202:Cardiomyopathies / Q000150:complications / Q000503:physiopathology; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology; D004231:Diuresis / Q000187:drug effects; D005292:Ferricyanides / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007668:Kidney / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D009569:Nitric Oxide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use
D005292:Ferricyanides; D014665:Vasodilator Agents; D009569:Nitric Oxide